Evidence map›Paper›PMID 40439672›Full record

ArticleBriefings in bioinformatics2025

LightCTL: lightweight contrastive TCR-pMHC specificity learning with context-aware prompt.

Fei Ye, Mao Chen, Yixuan Huang, Ruihao Zhang, Xuqi Li, Xiuyuan Wang, Sanyang Han, Lan Ma, Xiao Liu

Abstract read
In one paragraph

Article in Briefings in bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fei YeInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.ORCID 0000-0001-9512-3625
Mao ChenInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Yixuan HuangInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Ruihao ZhangInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Xuqi LiInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Xiuyuan WangInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Sanyang HanInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Lan MaInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.
Xiao LiuInstitute of Biopharmaceutical and Health Engineering, Tsinghua ShenZhen International Graduate School, Tsinghua University, Lishui Road, Nanshan District, Shenzhen, Guangdong Province 518055, China.

Funding

Scientific Research Start-up Funds QD2021005NShenzhen Science and Technology Program WDZC20220819134430002Shenzhen Universities Stable Funding Key Projects WDZC20200821104802001
6 · The paper itself

Abstract

Identification of T cell receptor (TCR) specificities for antigens from large-scale single-cell or bulk TCR repertoire data plays a vital role in disease diagnosis and immunotherapy. In silico prediction models have emerged in recent years. However, the generalizability and transferability of current computational models remain significant hurdles in accurately predicting TCR-pMHC binding specificity, primarily due to the limited availability of experimental data and the vast diversity of TCR sequences. In this paper, we propose a lightweight contrastive TCR-pMHC learning with context-aware prompts, named LightCTL, to infer TCR-pMHC binding specificity. For each TCR and peptide-MHC sequence, we utilize a TCR encoding module and a pMHC encoding module to transform them into latent representations. Specifically, we introduce a contrastive TCR-pMHC learning paradigm to enhance the generalization ability of TCR-pMHC binding specificity prediction by learning the matching relationship between TCR-pMHC and MHC-peptide. We fuse the TCR and pMHC latent representations and employ a novel context-aware prompt module to consider the varying importance of different feature maps. Compared with existing methods, LightCTL substantially improves the accuracy of predicting TCR-pMHC binding specificity. Moreover, comparative experiments across eight independent datasets demonstrate the generalization ability of LightCTL, showing superior performance for predicting unknown TCR-pMHC pairs. Finally, we assess LightCTL's efficacy across different TCR sequence lengths and distinct unseen epitopes, as well as estimate cytomegalovirus-specific TCR diversity and clone frequency from peripheral TCR repertoire data. Overall, our findings highlight LightCTL as a versatile analytical method for advancing novel T-cell therapies and identifying novel biomarkers for disease diagnosis.

Indexed as

Computational BiologyMachine LearningReceptors, Antigen, T-CellHumansProtein BindingReceptors, Antigen, T-Cellcontext-aware promptcontrastive learninglightweightTCR–pMHC binding specificity

Identifiers

PMID40439672
PMCPMC12121355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.